Equitable Holdings’s SELLAS Life Sciences SLS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-32,060	Closed	-$121K	–	1751
2025 Q4	$121K	Buy	32,060 +5,000	+18%	+$9.72K	﹤0.01%	1532
2025 Q3	$43.6K	Buy	27,060 +10,000	+59%	+$17.8K	﹤0.01%	1510
2025 Q2	$37.4K	Buy	17,060 +5,000	+41%	+$7.67K	﹤0.01%	1442
2025 Q1	$13K	Hold	12,060	–	–	﹤0.01%	1333
2024 Q4	$12.5K	Hold	12,060	–	–	﹤0.01%	1261
2024 Q3	$15.1K	Sell	12,060 -197,940	-94%	-$242K	﹤0.01%	1255
2024 Q2	$250K	Buy	210,000 +10,000	+5%	+$13.6K	﹤0.01%	1049
2024 Q1	$202K	Buy	200,000 +35,000	+21%	+$29.4K	﹤0.01%	1093
2023 Q4	$175K	Buy	165,000 +30,000	+22%	+$32.5K	﹤0.01%	1076
2023 Q3	$221K	Hold	135,000	–	–	﹤0.01%	971
2023 Q2	$212K	Buy	135,000 +5,000	+4%	+$8.03K	﹤0.01%	969
2023 Q1	$186K	Buy	130,000 +17,000	+15%	+$42.1K	﹤0.01%	933
2022 Q4	$267K	Buy	113,000 +3,000	+3%	+$8.41K	﹤0.01%	768
2022 Q3	$222K	Hold	110,000	–	–	﹤0.01%	774
2022 Q2	$245K	Buy	110,000 +6,000	+6%	+$17.6K	﹤0.01%	755
2022 Q1	$695K	Buy	104,000 +2,000	+2%	+$11.7K	0.01%	500
2021 Q4	$564K	Buy	102,000 +2,000	+2%	+$15.1K	0.01%	541
2021 Q3	$916K	Buy	100,000 +5,700	+6%	+$52.9K	0.02%	403
2021 Q2	$1.05M	Hold	94,300	–	–	0.02%	360
2021 Q1	$805K	Hold	94,300	–	–	0.02%	399
2020 Q4	$548K	Buy	94,300 +34,000	+56%	+$136K	0.01%	439
2020 Q3	$160K	Buy	+60,300	New	+$165K	﹤0.01%	602